Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 82278

25 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
February 21, 2019
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

25 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 25

SODIUM CHLORIDE PRES-FREE 5% OPHTH STERILE* SOLUTION. 20ml eye drops, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

D-1086-2019
Recall number
D-1086-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
1 prescription 20ml solution

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot: 12022019@30, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 2 of 25

DEXAMETHASONE (NAPO4) 0.1% OPHTH* PRES-FREE SOLUTION, 10ml, Eye Drops, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

D-1087-2019
Recall number
D-1087-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
12 prescriptions

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lots: 23012019@48, 24012019@2, 24012019@36, 28012019@35, 29012019@13, 05022019@5, 11022019@13, 12022019@20, 19022019@1, 19022019@6, 19022019@57, 19022019@61, All lots within expiry distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 3 of 25

ACETYL-L-CYSTEINE 10% P.F. OPHTH SOLUTION, 10ml, eye drops, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

D-1088-2019
Recall number
D-1088-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
6 prescriptions 10ml dropper bottle

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lots: 17012019@13, 30012019@36, 01022019@4, 14022019@1, 19022019@18, 19022019@60, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 4 of 25

HYDROXYPROGESTERONE CAPROATE 250 MG/ML OIL* INJECTABLE, (a) 10ml (b) 9ml injectable, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

D-1089-2019
Recall number
D-1089-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
4 prescriptions 9 & 10ml injectable

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lots: (a) 01112018@19, 04012019@52, 14022019@23, (b) 14012019@36, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 5 of 25

PAPAVERINE-PHENTOLAMINE-PGE1 22-0.8 MG-8 MCG/ML* INJECTABLE, (a) 5ml (b) 10ml, (c) 6ml, penile injection, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

D-1090-2019
Recall number
D-1090-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
64 prescriptions 5, 10, 6 mL injections

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot: (a) 18092018@52, 01102018@9, 05102018@36, 08102018@11, 102018@9, 01102018@9, 01102018@9, 03102018@27, 12102018@18, 01102018@9, 12102018@18, 12102018@18, 17102018@15, 12102018@18, 2102018@18, 22102018@31, 30102018@22, 29102018@9,29102018@9 29102018@9, 29102018@9, 12102018@18, 21112018@38, 21112018@38, 21112018@38, 21112018@38, 21112018@38, 21112018@38, 11122018@7, 11122018@7, 28122018@11, 28122018@11, 28122018@11, 03012019@17, 03012019@17, 03012019@17, 08012019@21, 08012019@21,28082018@16 28082018@16, 28082018@16, 14092018@28, 14092018@28, 4092018@28, 14092018@28, 18092018@52, 18092018@52, 8092018@52, 18092018@52, 18092018@52, (b) 29102018@9, 03012019@17,14092018@28, (c) 11012019@64, 11012019@64, 11012019@64, 05022019@27, 5022019@27, 06022019@6, 06022019@6, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 6 of 25

PGE1 40 MCG/ML* INJECTABLE, (2) 5ml (b) 10ml, (c) 6ml (d) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

D-1091-2019
Recall number
D-1091-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
5 prescriptions 5,10, 6, 9 ml injectable

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot:(a) 10102018@30, (b) 31102018@33,05112018@1, (c)15012019@8, (d) 30012019@33, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 7 of 25

PAPAVERINE-PHENTOLAMINE 30-1 MG/ML* INJECTABLE, (a)10ml (b) 9ml, penile injection, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

D-1092-2019
Recall number
D-1092-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
3 prescriptions 10, 9, ml injection

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot:(a) 08102018@11, 27122018@33, (b) 30012019@43, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 8 of 25

PAPAVERINE-PHENTOLAMINE-PGE1 30-1 MG-10 MCG/ML* INJECTABLE, (a) 5ml, (b) 6ml, (c) 9ml (d) 10ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

D-1093-2019
Recall number
D-1093-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
13 prescription 5, 6, 9, 10 ml injection

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot: (a) 03102018@27, 07112018@18, 08112018@11, 16112018@15, 28112018@7, 14122018@37,16112018@41, 03012019@9, (b) 2012019@32, 23012019@59, (c)07022019@19, 07022019@1, (d)19122018@25, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 9 of 25

PAPAVERINE-PHENTOLAMINE-PGE1 12-1MG-10MCG/ML INJECTABLE, (a) 10ml, (b) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

D-1094-2019
Recall number
D-1094-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
9 prescriptions 10, 9ml injection

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot (a)17102018@15,14112018@3, 04122018@21, 14122018@15, 7122018@11, 28122018@69, 20092018@2, (b) 21012019@37, 22012019@31, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 10 of 25

PAPAVERINE-PHENTOLAMINE-PGE1 17.16-0.57MG-19.45MCG/ML* INJECTABLE, 5ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

D-1095-2019
Recall number
D-1095-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
2 prescription 5ml injection

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot 30102018@22, 15112018@5, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 11 of 25

PAPAVERINE-PHENTOLAMINE-PGE1 23-0.96MG-19.2MCG/ML INJECTABLE, (a) 5ml, (b) 6.5ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

D-1096-2019
Recall number
D-1096-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
2 prescription 5, 6.5 ml injection

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot: (a) 22102018@31, (b) 09112018@33, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 12 of 25

PAPAVERINE-PHENTOLAMINE-PGE1 30-1.6 MG-16 MCG/ML* INJECTABLE, (a) 5ml, (b) 10ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

D-1097-2019
Recall number
D-1097-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
3 prescription 5, 10 ml injection

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot: 05102018@36,27112018@49, (b) 28112018@54, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 13 of 25

PGE1-LIDOCAINE 40 MCG-1% /ML* INJECTABLE, (a) 10 ml (b) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

D-1098-2019
Recall number
D-1098-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
25 prescriptions 10, 9, ml injectable

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot:(a) 26092018@22, 26092018@22, 09102018@47, 15102018@33, 15102018@33, 09102018@47, 15102018@33, 09102018@47, 29112018@4, 10122018@14, 29112018@4, 29112018@4, 19122018@20, 21122018@29, 21122018@29, 27122018@20, (b) 16012019@59, 18012019@17, 21012019@49, 21012019@49, 22012019@24, 22012019@24, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 14 of 25

PAPAVERINE-PHENTOLAMINE 15-0.5MGMG/ML INJECTABLE, 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

D-1099-2019
Recall number
D-1099-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
1 prescription 9ml injectable

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot:15012019@10, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 15 of 25

PAPAVERINE-PHENTOLAMINE 30-0.5 MG/ML INJECTABLE, 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

D-1100-2019
Recall number
D-1100-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
1 prescription, 9ml injectable

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot:19022019@21, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 16 of 25

PAPAVERINE-PHENTOLAMINE-PGE1 30-2 MG-30 MCG/ML* INJECTABLE, 5ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

D-1101-2019
Recall number
D-1101-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
1 prescription, 5ml injectable

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot:15112018@40 , distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 17 of 25

PAPAVERINE-PHENTOLAMINE-PGE1 15-0.5MG-10MCG/ML INJECTABLE, 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

D-1102-2019
Recall number
D-1102-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
1 prescription, 9ml injection

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot:17012019@27, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 18 of 25

PAPAVERINE-PHENTOLAMINE-PGE1 16.6-0.55 MG-11.1 MCG/ML* INJECTABLE, 10 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

D-1103-2019
Recall number
D-1103-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
2 pre4scriptions 10 ml injections

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot:09112018@55, 09012019@37, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 19 of 25

PAPAVERINE-PHENTOLAMINE-PGE1 17.64-0.58MG-5.88MCG/ML* INJECTABLE, 9 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

D-1104-2019
Recall number
D-1104-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
1 prescription 9ml injection

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot:17012019@18, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 20 of 25

PAPAVERINE-PHENTOLAMINE-PGE1 22.5-0.8MG-8.3MCG/ML INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

D-1105-2019
Recall number
D-1105-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
2 prescriptions, 5ml injection

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot:26112018@68, 13122018@12, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 21 of 25

PAPAVERINE-PHENTOLAMINE-PGE1 9-1 MG-10 MCG/ML* INJECTABLE, 18 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

D-1106-2019
Recall number
D-1106-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
1 prescription, 18ml injection

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot:12022019@23, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 22 of 25

PAPAVERINE-PHENTOLAMINE-PGE1 30-1 MG-20 MCG/ML* INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

D-1107-2019
Recall number
D-1107-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
3 prescriptions, 5ml injectable

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot:20092018@41, 25092018@7, 27092018@3, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 23 of 25

PAPAVERINE-PHENTOLAMINE-PGE1 15-0.25MG-6MCG/ML INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

D-1108-2019
Recall number
D-1108-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
1 prescription, 5ml injection

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot:06092018@57, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 24 of 25

PAPAVERINE-PHENTOLAMINE-PGE1 17.44-0.58MG-5.8MCG/ML* INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

D-1109-2019
Recall number
D-1109-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
1 prescription, 5ml

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot:19092018@1, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

drug · product 25 of 25

PAPAVERINE-PHENTOLAMINE-PGE1 17.44-0.64MG-5.8MCG/ML* INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .

D-1110-2019
Recall number
D-1110-2019
Initiated
February 21, 2019
Classification
Class II
Status
Terminated
Quantity
1 prescription, 5ml injection

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
Lack of Processing Controls

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information

Lot:13092018@44, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern

Dispensed in Oregon

Field note

Send feedback

We'll only use this to respond to your feedback.